Breaking Out: Is semiconductor stock Archer back on target?

Breaking Out is a technical analysis-fuelled, short ‘n’ sharp take on chart-busting ASX stocks. Each week, Steve Collette – head of Collette Capital in Melbourne – narrows in on something that’s caught his eye.

Archer Materials (ASX:AXE)

Archer is one of a handful of micro-cap companies listed locally with credible expertise in the semiconductor industry.

Their announcements remain intriguing and somewhat cryptic, leaving room for them to capture the zeitgeist on the upside when the market is looking for exposure in this style.

The price action is no stranger to strong trends and significant moves in both directions.

To that end, Archer has recently shown signs of some renewed speculation.

After peaking at 60c in late March, the stock committed to a proper downtrend that saw it drop to below 20 cents by late September. However, it has since started to show signs of recovery, moving into modest uptrend with potential upside targets if interest in the sector continues.

BrainChip Holdings (ASX:BRN) and Strategic Elements (ASX:SOR) are two other names in the adjacent space that we keep an eye on to gauge speculative appetite.

For Archer, on the downside, the gap-fill back to 21c needs to hold.

Trading above 30c at the time of writing, the next significant resistance level is at the 200-day moving average of 34.5c.

Beyond this level, there is potential to 45c, and beyond that a retest of the 60c level seen earlier this year.

Archer is sitting at half of its 60c March high. Pic: Bloomberg

Collette Capital offers IMA services to wholesale clients only.

The IMA has returned 17.89% p.a. net of any fees as at end October 2024 since January 2015.

Learn more at www.collette.capital Collette Capital is a Corporate Authorised Representative (CAR: 128443) of Sanlam Private Wealth (AFSL 337927 ), and only provides general advice.

Collette Capital advise that they and persons associated with them may have an interest in the above securities.

The views, information, or opinions expressed in the interviews in this article are solely those of the contributing author and do not represent the views of Stockhead.

Stockhead does not provide, endorse or otherwise assume responsibility for any financial product advice contained in this article.